Anorectics

FDA panel recommends approval of anti-obesity drug

Health & Medicine

An advisory panel of outside physicians for the FDA recommended approval of the weight-loss drug Qnexa, which was previously rejected in 2010. Pending approval, Qnexa could be the most effective non-surgery treatment for obese people. The FDA will make a final decision later this year.

Why San Diego is the Biggest Entry Point for Mexican Meth

Arts, Culture & Media

Anti-Obesity Drug Approved by FDA Advisory Panel

Colombia’s Latest Tack Against Drug Production

Global Politics
Tell us about your experience accessing The World

We want to hear your feedback so we can keep improving our website, theworld.org. Please fill out this quick survey and let us know your thoughts (your answers will be anonymous). Thanks for your time!

We respect your time, attention and privacy

This is a news website, not a click casino. We do NOT employ deceptive behaviors, display annoying ads or use third party cookies and trackers to monetize your visit or help advertisers track you across the internet.

Simply, we ask that you would consider a donation to support the journalism we produce every weekday. Thank you.